OrganiGram

What OrganiGram does

Organigram Global Inc. (TSX/NASDAQ: OGI) is Canada's largest cannabis producer by recreational net revenue, operating five purpose-built facilities across Canada (Moncton, Winnipeg, Aylmer, London, and Lac-Supérieur) with a combined annual production capacity exceeding 20,000 kg. Founded in 2013 as a medical cannabis provider and rebranded to Organigram Global in 2024, the company manufactures flower, pre-rolls, vapes, edibles (up to 4M gummies/month at Winnipeg), concentrates (up to 1,200 kg distillate/month at Aylmer), and beverages under a portfolio of brands including SHRED (milled flower, pre-rolls, gummies, hash), BOXHOT (vapes with 20%+ Canadian category share), Edison (premium innovation including JOLTS lozenges and FAST™ nanoemulsion gummies), Big Bag o' Buds (value), Trailblazer, DEBUNK, Tremblant, Monjour, and Collective Project. The company's principal technology differentiator is its patent-pending FAST™ nanoemulsion platform, clinically validated to deliver ~50% faster onset and nearly double cannabinoid delivery versus traditional edibles, and applied across gummies, lozenges, and beverages.

Organigram generates revenue primarily through wholesale supply to Canadian provincial cannabis boards (Ontario Cannabis Store, BC Liquor Distribution Branch, SAQ, etc.) for recreational products, with additional revenue from medical cannabis sales in Canada, Germany, Australia, and the UK via pharmacy networks and telemedicine. The company pursues a multi-channel distribution model: direct sales to provincial boards and retailers in Canada, international export partnerships (Sanity Group in Germany with 2,000+ pharmacy reach, Leafio/Montu in Australia with 4,000+ pharmacies), and U.S. retail distribution of hemp-derived THC beverages and gummies via Total Wines and Top 10 Liquors. Customer segments span recreational consumers across price points (value to premium), medical patients in multiple jurisdictions, and international distributors seeking EU-GMP-certified supply. Most recently, Q2 FY2026 net revenue was $59.8M USD (down 9% YoY) with management targeting >C$300M for FY2026.

The company's strategic capital partner is British American Tobacco (BAT), which has invested over $345M CAD across three tranches (2021, 2023/24, 2026) to reach approximately 48.4% ownership. BAT funds the Jupiter Strategic Investment Pool earmarked for further U.S./international M&A and supports a Centre of Excellence for next-generation cannabis product R&D at Moncton. In December 2024 Organigram acquired Motif Labs to achieve #1 Canadian market position; in April 2025 it acquired Collective Project to enter the U.S. hemp-derived THC beverage category; and in April 2026 it completed the acquisition of Sanity Group GmbH for €107.3M upfront plus up to €113.8M in earnout, establishing a leading position in the German federally legal cannabis market. The company is led by CEO James Yamanaka (effective January 2026), formerly Global Head of Strategy at BAT.

Name

OrganiGram

Legal name

Organigram Inc.

Website

https://organigram.ca

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Organigram Global is Canada's #1 cannabis producer, manufacturing flower, vapes, edibles, and beverages across five facilities. It sells recreational and medical cannabis under brands including SHRED, BOXHOT, and Edison in Canada, Germany, Australia, the UK, and the US.

Ownership category

akta.pro rank

Product category

Cannabis Products

NAICS

Medicinal and Botanical Manufacturing (325411), Beverage Manufacturing (3121)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)

akta.pro secondary industries

Herbal & Botanical Supplements (CRADAGAD), Botanical/Herbal & Adaptogen Functional Beverage Production (AFAFAFAF)

Keywords

• Recreational cannabis products
• Medical cannabis supply
• Cannabis cultivation production
• Cannabis brand portfolio
• Hemp-derived THC beverages

Headquarters

HQ city

Moncton

HQ country

Canada

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Recreational Cannabis Sales: Sale of recreational cannabis products through Canadian provincial boards and retailers. Products include flower, pre-rolls, vapes, edibles, and concentrates across multiple brand portfolios. Revenue subject to Canadian excise duties.
2. Medical Cannabis Sales: Sale of medical cannabis products to patients in Canada and international markets including Germany, Australia, and UK through pharmacies and telemedicine platforms.
3. U.S. Hemp-Derived THC Beverages: Sale of hemp-derived THC beverages through Collective Project brand in U.S. states where permitted, reaching consumers via Total Wines, Top 10 Liquors, and other retailers.
4. International Export: Export of cannabis flower and products to international markets. International shipments are not subject to Canadian excise duties, providing higher margin potential upon EU-GMP certification.

Go-to-market motion4 records

Distribution channels6 records

Marketing channels6 records

Core offering

Organigram Global is a Canadian licensed producer that cultivates, manufactures, and distributes medical and recreational cannabis products, including dried flower, pre-rolls, vapes, edibles, and beverages, across a portfolio of consumer brands. The company operates five purpose-built production facilities in Canada and distributes through Canadian provincial boards, international pharmacy networks, and U.S. retail channels for hemp-derived THC beverages.

Product overview

OrganiGram operates a diversified cannabis product portfolio spanning multiple categories including flower, concentrates, vapes, edibles, and beverages. The company holds the #1 market position in Canada across several categories. Core brands include SHRED (mainstream, $224M annual retail sales), BOXHOT (leading vape brand, $150M annualized sales), and Edison (premium innovation). The company pioneered FAST™ patent-pending nanoemulsion technology enabling faster-onset edibles and beverages. Brands range from value-oriented (Big Bag o' Buds) to premium (Edison, Trailblazer), serving both recreational and wellness consumers. International expansion includes hemp-derived THC products (happly, Collective Project) in the US market.

Differentiator

Problem solved

Functional benefit

Brands

• SHRED: Award-winning mainstream brand with $224 million in annual retail sales; leads in milled flower, pre-rolls, gummies, and Rip Strip Hash
• BOXHOT
• Edison
• Big Bag o' Buds
• DEBUNK
• Rizzlers
• Trailblazer
• Monjour
• Tremblant
• Collective Project
• Happly
• Fetch
• Wola

Products and services

• SHRED Mainstream cannabis brand offering pre-milled flower, gummies, hash strips, and infused pre-rolls for adult recreational consumers.
• BOXHOT Leading high-potency cannabis vape brand with portfolio of vapes, infused pre-rolls, and distillate products for recreational consumers.
• Edison Premium cannabis brand featuring innovative product formats such as ingestible lozenges and FAST™ nanoemulsion edibles for premium experience seekers.
• Edison Sonics Gummies FAST™ nanoemulsion cannabis gummies with clinically proven faster onset and higher bioavailability than traditional edibles.
• SHRED Shotz Cannabis-infused nanoemulsion shot beverage with 10mg THC per 65ml serving, designed for faster onset versus traditional edibles.
• Big Bag o' Buds Value-priced cannabis brand offering whole-flower cannabis in various sizes and pre-rolls for budget-conscious recreational consumers.
• DEBUNK Premium high-potency cannabis vapes, concentrates, and infused pre-rolls targeting experienced consumers seeking bold flavors.
• Rizzlers Cannabis vape products with flavor-focused high-potency inputs paired with user-friendly hardware.
• Trailblazer High-THC cannabis flower and pre-rolls, hang-dried, hand-packed, and sealed in glass jars for premium consumers.
• Monjour CBD-forward cannabis edibles infused with minor cannabinoids such as CBG and CBN, formulated as vegan-friendly wellness products.
• Tremblant Premium hash products using traditional craftsmanship techniques, including hand-rolled hash balls and pressed varieties.
• Collective Project Flavor-forward cannabis and hemp-derived THC beverage brand available in Canadian and U.S. retail channels.
• Fetch Accessibly priced cannabis beverages in nostalgic flavors, offered in regular and zero-sugar options.
• happly Hemp-derived THC gummies with mood-state-targeted formulations (Socialize, Relax, Sleep) using FAST™ nanoemulsion technology for the U.S. market.
• Wola Quebec-focused cannabis brand featuring locally grown flower, smooth-burning pre-rolls, and traditional hash.
• Rip-Strips Hash Tear-off hash strips allowing portion-controlled use, sold under the SHRED brand.
• Edison and BOXHOT Medical Cannabis Vapes and Pastilles (Australia) Medical cannabis vape and pastille product range launched in Australia via Leafio distribution covering over 4,000 pharmacies.

Quantifiable outcome

• ~50% faster onset compared to traditional edibles with nearly double cannabinoid delivery at peak effect
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Leafio (Montu Australia)coreChannel Partner/ Reseller/ Distributor · 24 February 2026Distribution partnership for 10 Edison and BOXHOT medical cannabis vape and pastille SKUs across 4,000+ Australian pharmacies via Leafio's nationwide supply chain.
• Phylos BiosciencecoreTechnology or Integration · 31 December 2025$10 million investment providing priority access to autoflower genetics pipeline including 30 new genetics delivered twice annually through 2030. Five-year exclusive rights for selected genetics in Canada, Australia, UK, Germany, and Israel. Advancing seed-based cultivation strategy.
• Collective ProjectcoreStrategic or Co-development Partner · 1 April 2025Acquisition of U.S. hemp-derived THC beverage company enabling entry into U.S. market. Products available in 10+ states including Total Wines and Top 10 Liquors. Brand leverages Collective Arts cultural positioning.
• Motif LabscoreStrategic or Co-development Partner · 1 December 2024Acquired December 2024 for undisclosed amount, Motif Labs acquisition propelled Organigram to #1 market position in Canada. Added extraction facility, logistics hub, vape and pre-roll production capabilities, and identified $10 million in annual cost synergies.
• Sanity GroupcoreStrategic or Co-development Partner · 15 April 2024Organigram acquired Sanity Group in April 2026 for €107.3 million upfront plus earnout. Sanity Group operates Germany's largest medical cannabis distribution network with 2,000+ pharmacy relationships and telemedicine platform. Provides Organigram access to rapidly growing European market.

Scale indicators19 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Tilray Brands: Largest Canadian licensed producer with a diversified cannabis portfolio spanning flower, vapes, edibles, beverages, and wellness. Tilray is Organigram's most direct competitor in the Canadian recreational market and similarly pursuing international and U.S. beverage expansion.
• Canopy Growth: Major Canadian licensed producer with broad recreational and medical cannabis offerings, including Tweed and Spectrum Cannabis brands. Competes directly with Organigram across Canadian provincial board channels and is pursuing global medical cannabis expansion.
• Aurora Cannabis: Canadian licensed producer focused on medical cannabis globally and recreational in Canada. Comparable to Organigram in vertical integration and international medical distribution strategy.
• Cronos Group: Canadian licensed producer with strategic backing from Altria. Closely comparable to Organigram in pairing a tobacco-industry strategic shareholder with multi-country cannabis operations and product innovation focus.
• Trulieve Cannabis: U.S. multi-state operator with vertically integrated cultivation, extraction, and retail. Comparable to Organigram in scale-driven, multi-state strategy, though focused on U.S. state-legal medical and adult-use markets.
• Curaleaf Holdings: U.S. multi-state cannabis operator with broad product portfolio across flower, vapes, edibles, and beverages. Comparable to Organigram's diversified product mix and international expansion ambitions.
• Green Thumb Industries: U.S. cannabis operator with national brand portfolio across multiple states. Similar vertical integration and brand-led growth model to Organigram's SHRED, BOXHOT, and Edison portfolio.
• SNDL Inc. Canadian licensed producer with retail and cultivation assets, competing across recreational flower and value-priced formats. Comparable to Organigram's mainstream positioning through Big Bag o' Buds and SHRED.
• Village Farms International: Canadian greenhouse operator with cannabis division producing dried flower, pre-rolls, and edibles. Comparable to Organigram in leveraging large-scale greenhouse and indoor cultivation for cannabis production.

Broad incumbents

• High Tide: Canadian cannabis retailer with proprietary e-commerce platform and accessories business. Adjacent to Organigram's wholesale and brand portfolio through its retail distribution focus and CPG-style accessory merchandising.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/organigram
• Instagraminstagram.com/organigram_global
• Xx.com/OrganiGramInc
• Facebookfacebook.com/OrganiGramInc

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries7 records

Funding overview

Funding rounds14 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OrganiGram